HEPAROSAN

Product Description

Building on the success of hyaluronic acid, HTL now wants to bring heparosan to market. Heparosan is a promising new biopolymer for the design of innovative medical and pharmaceutical devicesHeparosan is a glycosaminoglycan, a natural biopolymer, produced by HTL Biotechnology from substances of non-animal origin. Heparosan has a structure and basic functionalities very similar to those of hyaluronic acid, with additional functionalities. Produced by biofermentation using an exclusive HTL biotechnology strain, it has longer-lasting effects because it is not degraded by hyaluronidase enzymes. It enables easy gel production for medical injectable applications

HTL

  • FR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Specifications
  • CAS Registry Number
    1544497-09-7
  • Selling Points
    Quality Service
  • Supplied from
    France
  • Measured In
    gram

HTL

  • FR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer

More Products from HTL (4)

  • HYALURONIC ACID

    Product HYALURONIC ACID

    Hyaluronic acid, also known as Hyaluronan, is a biopolymer that is naturally present in the human body. It has been used for many years as a raw material or ingredient for medical products in various fields including ophthalmology, rheumatology medical aesthetics and dermatology.
    HTL Biotechnolog...
  • Functionalized Hyaluronic Acid

    Product Functionalized Hyaluronic Acid

    HTL Biotechnology offers expert guidance and support to companies venturing into the industrial production of a modified Hyaluronic Acid compound, ensuring transparent and efficient processes.

    New functionalities thanks to chemical modification: 
    Optimizing ...
  • PDRN (Polydeoxyribonucleotide)/ PN (Polynucleotide)

    Product PDRN (Polydeoxyribonucleotide)/ PN (Polynucleotide)

    PDRN is a fast-growing biopolymer with unique advantages. Our company has 45 years' experience in DNA production. We are recognized for being able to supply DNA for topical and injectable applications, with a very low level of impurities. 
    Key role at molecular level : 
    - Key role in cell...
  • SODIUM DNA

    Product SODIUM DNA

    Sodium DNA is a raw material for cosmetics with unique properties. Our company has 45 years' experience in DNA production. We are recognized for our ability to supply DNA for topical and injectable applications, with very low levels of impurities. Sodium DNA, is DNA that has been extracted and purified to ...

HTL resources (5)

  • News HTL Biotechnology at IMCAS World congress Paris 2024

    IMCAS, the world’s leading congress dedicated to dermatology, plastic surgery, and aesthetics.
  • Video HTL Biotechnology video - Beyond, Together.

    Feel the difference with HTL inside !
    HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.

    Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 400 million syringes of hyaluronic acid have been safely used since 2006.

    At HTL Biotechnology, our mission is to unleash the potential of Hyaluronic Acid and biopolymers.

    For over 30 years, our teams have been developing and perfecting a pharmaceutical-grade biopolymer platform that provides customized solutions to pharmaceutical laboratories and medical device manufacturers worldwide in therapeutic areas such as Ophthalmology, Rheumatology, Dermatology and Medical Aesthetics.

  • News HTL Biotechnology at CPHI 2023 Barcelona

    The biggest international pharma industry event is back in Barcelona.The HTL team was present to welcome people and discuss our products and values, also our latest advancements with biopolymers for medical applications.
  • Brochure Discover our company

    Feel the difference with HTL inside !
    HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.

    Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 400 million syringes of hyaluronic acid have been safely used since 2006.

    At HTL Biotechnology, our mission is to unleash the potential of Hyaluronic Acid and biopolymers.

    For over 30 years, our teams have been developing and perfecting a pharmaceutical-grade biopolymer platform that provides customized solutions to pharmaceutical laboratories and medical device manufacturers worldwide in therapeutic areas such as Ophthalmology, Rheumatology, Dermatology and Medical Aesthetics.
  • News Our new CSR strategy

    HTL Biotechnology's new corporate social responsibility strategy will focus on accelerating the company’s commitment to its environment, local ecosystem and employees. 

    HTL Biotechnology's engagements have been awarded an Ecovadis gold medal in 2023 and are certified by ISO 14001:2015.